Barriers in the brain: a renaissance?

Barrier mechanisms regulate the exchange of molecules between the brain's internal milieu and the rest of the body. Correct functioning of these mechanisms is critical for normal brain activity, maintenance and development. Dysfunctional brain barrier mechanisms contribute to the pathology of neurological conditions, ranging from trauma to neurodegenerative diseases, and provide obstacles for successful delivery of potentially beneficial pharmaceutical agents. Previous decades of research have yielded insufficient understanding for solving brain barrier problems in vivo. However, an awakening of interest and novel approaches are providing insight into these mechanisms in developing and dysfunctional brain, as well as suggesting new approaches to circumventing brain barrier mechanisms to get therapeutic agents into the central nervous system.

[1]  Wolfgang Löscher,et al.  Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases , 2005, Progress in Neurobiology.

[2]  S. Nag The blood-brain barrier : biology and research protocols , 2003 .

[3]  E. Fernell,et al.  Aberrant amino acid transport in fibroblasts from children with autism , 2007, Neuroscience Letters.

[4]  D. Spray,et al.  Blood-brain barriers : from ontogeny to artificial interfaces , 2006 .

[5]  W. Pardridge Blood-Brain Barrier Genomics , 2007, Stroke.

[6]  H. Stolp,et al.  Breakdown of the blood–brain barrier to proteins in white matter of the developing brain following systemic inflammation , 2005, Cell and Tissue Research.

[7]  J. Gaughan,et al.  Effects of crystalloid-colloid solutions on traumatic brain injury. , 2007, Journal of neurotrauma.

[8]  W. Pan,et al.  Increased hippocampal uptake of tumor necrosis factor α and behavioral changes in mice , 2003, Experimental Brain Research.

[9]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[10]  Sean M. Grady,et al.  Clinical trials in head injury. , 1999, Journal of neurotrauma.

[11]  H. Stolp,et al.  Functional effectiveness of the blood‐brain barrier to small water‐soluble molecules in developing and adult opossum (Monodelphis domestica) , 2006, The Journal of comparative neurology.

[12]  I. Blasig,et al.  In Search of the Astrocytic Factor(s) Modulating Blood–Brain Barrier Functions in Brain Capillary Endothelial Cells In Vitro , 2005, Cellular and Molecular Neurobiology.

[13]  T. Takano,et al.  Astrocyte-mediated control of cerebral blood flow , 2006, Nature Neuroscience.

[14]  K. Hayashi,et al.  Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells , 2007, Cellular and Molecular Neurobiology.

[15]  B. Wiesner,et al.  Formation of tight junction: determinants of homophilic interaction between classic claudins , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Michael Jerosch-Herold,et al.  THE POTENTIAL OF FERUMOXYTOL NANOPARTICLE MAGNETIC RESONANCE IMAGING, PERFUSION, AND ANGIOGRAPHY IN CENTRAL NERVOUS SYSTEM MALIGNANCY: A PILOT STUDY , 2007, Neurosurgery.

[17]  P. Caliceti,et al.  Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. , 2003, Advanced drug delivery reviews.

[18]  A. Kakita,et al.  The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood–brain barrier of neonatal rats: A critical period for efficacy , 2007, Neuroscience.

[19]  H. Stolp,et al.  Blood–CSF barrier function in the rat embryo , 2006, The European journal of neuroscience.

[20]  Takahiro Takano,et al.  Two‐Photon Imaging of Astrocytic Ca2+ Signaling and the Microvasculature in Experimental Mice Models of Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[21]  S. Liddelow,et al.  The blood–CSF barrier explained: when development is not immaturity , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  N. Saunders,et al.  Structural characteristics and barrier properties of the choroid plexuses in developing brain of the opossum (Monodelphis Domestica) , 2003, The Journal of comparative neurology.

[23]  A. Leviton,et al.  Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences. , 2004, Early human development.

[24]  N. Bodor,et al.  Targeting of Neuropharmaceuticals by Chemical Delivery Systems , 2007 .

[25]  C. Ek,et al.  Changes in blood–brain barrier permeability to large and small molecules following traumatic brain injury in mice , 2007, The European journal of neuroscience.

[26]  Jean-Pierre Benoit,et al.  Active targeting of brain tumors using nanocarriers. , 2007, Biomaterials.

[27]  C. Capobianco,et al.  An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis , 2007, Angiogenesis.

[28]  H. Nawa,et al.  Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines , 2006, Neuroscience Research.

[29]  G. Knott,et al.  Barriers in the Immature Brain , 2000, Cellular and Molecular Neurobiology.

[30]  J. Haorah,et al.  Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions , 2006, Journal of Neuroimmune Pharmacology.

[31]  H. Stolp,et al.  Long‐term changes in blood–brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat , 2005, The European journal of neuroscience.

[32]  R. Knight,et al.  Acute Leakage Patterns of Fluorescent Plasma Flow Markers after Transient Focal Cerebral Ischemia Suggest Large Openings in Blood‐Brain Barrier , 2008, Microcirculation.

[33]  E. Neuwelt,et al.  An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. , 2005, AJNR. American journal of neuroradiology.

[34]  D. Lane,et al.  Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. , 2001, Bioconjugate chemistry.

[35]  D. Peebles,et al.  Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. , 2002, Mental retardation and developmental disabilities research reviews.

[36]  S. Nicosia,et al.  Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS , 2007, Brain Research.

[37]  S. Goderie,et al.  Asymmetric Distribution of EGFR Receptor during Mitosis Generates Diverse CNS Progenitor Cells , 2005, Neuron.

[38]  Hugh Davson,et al.  Physiology of the CSF and Blood-Brain Barriers , 1996 .

[39]  T. Terasaki,et al.  Contribution of Carrier-Mediated Transport Systems to the Blood–Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development , 2007, Pharmaceutical Research.

[40]  J. Nutt,et al.  Strategies to advance translational research into brain barriers , 2008, The Lancet Neurology.

[41]  Hartwig Wolburg,et al.  Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.

[42]  M. Papadopoulos,et al.  Water movements in the brain: role of aquaporins , 2008, Trends in Neurosciences.

[43]  H. Wolburg The Endothelial Frontier , 2007 .

[44]  R. Deane,et al.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. , 2007, Current Alzheimer research.

[45]  Alireza Minagar,et al.  Multiple sclerosis as a vascular disease , 2006, Neurological research.

[46]  A. Olsen,et al.  Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. , 2008, The Journal of general virology.

[47]  W. Pardridge,et al.  Intravenous siRNA of Brain Cancer with Receptor Targeting and Avidin–Biotin Technology , 2007, Pharmaceutical Research.

[48]  W. Pardridge,et al.  Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood–brain barrier , 2007, Biotechnology and bioengineering.

[49]  A. Minagar,et al.  The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis. , 2007, International review of neurobiology.

[50]  P. Marin,et al.  The proteomic analysis of mouse choroid plexus secretome reveals a high protein secretion capacity of choroidal epithelial cells , 2006, Proteomics.

[51]  Patricia M. Whitaker-Azmitia,et al.  Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? , 2005, International Journal of Developmental Neuroscience.

[52]  Ruth A. Rawson,et al.  THE BINDING OF T-1824 AND STRUCTURALLY RELATED DIAZO DYES BY THE PLASMA PROTEINS , 1943 .

[53]  Bradley E. Enerson,et al.  The Rat Blood—Brain Barrier Transcriptome , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  U. Landegren,et al.  Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. , 2007, Genes & development.

[55]  J. L. Bas,et al.  High-Resolution Blood–Brain Barrier Permeability and Blood Volume Imaging Using Quantitative Synchrotron Radiation Computed Tomography: Study on an F98 Rat Brain Glioma , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  H. Stolp,et al.  Effect of minocycline on inflammation‐induced damage to the blood–brain barrier and white matter during development , 2007, The European journal of neuroscience.

[57]  W. Pan,et al.  Receptor-mediated transport of LIF across blood–spinal cord barrier is upregulated after spinal cord injury , 2006, Journal of Neuroimmunology.

[58]  P. Carmeliet,et al.  Common mechanisms of nerve and blood vessel wiring , 2005, Nature.

[59]  D. Attwell,et al.  Bidirectional control of CNS capillary diameter by pericytes , 2006, Nature.